Sarah Boyce Insider Trading $LGND LIGAND PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sarah Boyce.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sarah Boyce. Sarah Boyce is Director in LIGAND PHARMACEUTICALS INC ($LGND) and Chief Business Officer in IONIS PHARMACEUTICALS INC ($ISIS) and President and CEO in Avidity Biosciences, Inc. ($RNA) and President in AKCEA THERAPEUTICS, INC. ($AKCA) and Director in Berkeley Lights, Inc. ($BLI).
Sarah Boyce in LIGAND PHARMACEUTICALS INC
Trading Symbol: LGNDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah Boyce: Director
Holdings: 2,892 shares
Current Value: $311,873
Latest Transaction: Jun 07 2021
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Sarah Boyce in LIGAND PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKCA, RNA, BLI, ISIS, LGND
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 630 | 0 | 2,892 | 2.3 K to 2.9 K (+27.85 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 630 | 0 | 2,892 | 2.3 K to 2.9 K (+27.85 %) |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 831 | 0 | 2,262 | 1.4 K to 2.3 K (+58.07 %) |
Oct 16 2019 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 107.81 | 5,283 | 569,560 | 5,283 | |
Oct 16 2019 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 1,431 | 0 | 1,431 | 0 to 1.4 K |
Page: 1